fbpx
QQQ
+ 4.49
336.53
+ 1.32%
DIA
-2.14
342.90
-0.63%
SPY
-0.11
422.22
-0.03%
TLT
+ 3.28
137.65
+ 2.33%
GLD
-4.61
175.72
-2.69%

Why Cowen Loves These 3 US Cannabis Stocks

April 20, 2021 1:53 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Why Cowen Loves These 3 US Cannabis Stocks

The U.S. House of Representatives passed legislation on Monday to allow banks to provide services to cannabis companies in states where it is legal.

Republicans are increasingly warming up to adult-use cannabis legalization given the jobs and tax revenue opportunities, Cowen Inc. analyst Vivien Azer said Tuesday on CNBC's "Squawk On The Street."

As more states move toward legalization of cannabis, the analyst said she likes three U.S names in particular.

"Our best idea" is Green Thumb Industries Inc (OTC:GTBIF), Azer said.

The analyst also has Outperform ratings on Curaleaf Holdings Inc (OTC:CURLF) and Trulieve Cannabis Corp (OTC:TCNNF).

Related Link: These OTC Securities Had The Most Trading Activity In March

Price Action: Green Thumb was down 2.11% to 26.58 at last check Tuesday.

Curaleaf was down 3.31% to $12.66 at last check Tuesday.

Trulieve was down 2.40% to $36.60 at last check Tuesday. 

(Image by Brent Barnett from Pixabay)

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

Analyst: Massachusetts Cannabis Store Count 'Is Growing Faster Than Sales'

Massachusetts has experienced an accelerated growth in cannabis stores, but this will not be the main catalyst for the state operators’ value.   Companies will likely see the upside in the state coming “from expanded cultivation,” according to Cantor Fitzgerald analyst Pablo Zuanic. read more

Can Past Medical Cannabis Sales Predict Rec Sales?

New Jersey is expected to start recreational cannabis sales either later this year or early next. Until then, it's not know what the combined med+rec sales will be, but Cantor Fitzgerald analyst Pablo Zuanic has a rough idea. He decided to take a look at the numbers in other states to help forecast what can be expected from the Garden State. read more

Florida's Medical Cannabis Market Remains 'Underpenetrated' Versus Rivals, Analyst Says

The Florida cannabis market is "quickly consolidating" and, while sequential growth has slowed, fourth-quarter flower volumes spiked 190%, according to Cantor Fitzgerald. The Thesis: "The state’s med market remains underpenetrated vs. other med markets (one-third AZ per cap)," analyst Pablo Zuanic wrote in the note. read more

Cannabis Analyst Reviews Sluggish Canadian Data: 'MSOs Will Outperform Again'

Hifyre Canadian cannabis sales data for the month of December is in, and the numbers suggest the Canadian retail cannabis market remains sluggish heading into 2021. read more